Recent News Releases

 
CSL Lifts Profit Guidance
18 May 2018 Company

CSL Limited today announced a revised profit outlook for
fiscal 2018.

World Haemophilia Day
16 Apr 2018 Company

CSL Behring Marks World Haemophilia Day by Shipping Bleeding Disorders Medicines to the World Federation of Haemophilia

1st Patient Enrollment in CSL112 Trial
23 Mar 2018 Company

The AEGIS-II trial will enrol more than 17,000 patients from approximately 1,000 medical centers around the world.

Making Forbes’ Top Global Employers List
20 Mar 2018 Company

Global biotech leader rated at no. 42 for patient focus, innovation and sustainable growth

CEO addresses EyeforPharma summit
13 Mar 2018 Company

- Industry’s role in ensuring access to medicine is an imperative, not an afterthought
- Patient engagement is a key driver to strengthen access

CSL Appoints New Directors
12 Dec 2017 Company

Dr Brian McNamee AO and Mr Abbas Hussain have been appointed as independent Non-Executive Directors, effective 14 February 2018.

Media Contacts

Christina Hickie

CSL Behring Australia
Senior Manager, Communications
Phone: +61 429 609 762

Want to know more about how CSL, and our CSL Behring division are sharing stories of biotech's promise?

Visit Vita
News archive 2016 pdf
News archive 2015 pdf
News archive 2014 pdf
News archive 2013 pdf

Get our latest news in your inbox

mail@example.com
First name
Last name
Country

Thanks!

Thank you for subscribing
to the CSL newsletter